|
WO2020187975A1
|
|
Patient selection for treatment with dendritic cell vaccination
|
|
EP3743099A1
|
|
Dendritic cell vaccination in parallel to chemotherapy
|
|
CA3088056A1
|
|
Dendritic cell vaccination sequential to chemotherapy
|
|
WO2017211816A1
|
|
Immunotherapy for cancer
|
|
GB201619906D0
|
|
Tolerogenic dendritic cells
|
|
CN107109366A
|
|
Tolerogenic dendritic cells, its generation method and application thereof
|
|
US2015184130A1
|
|
Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer
|
|
EP2829600A1
|
|
Method for preparing dendritic cells to be used as antigen-presenting cells in immunotherapy
|
|
US2013011438A1
|
|
Means And Methods For Active Cellular Immunotherapy Of Cancer By Using Tumor Cells Killed By High Hydrostatic Pressure and Dendritic Cells
|
|
MX2013013243A
|
|
Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure and dendritic cells.
|
|
EP2682750A1
|
|
In vitro method for the diagnosis and surveillance of cancer
|
|
EP2543386A1
|
|
Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure
|
